Autolus Therapeutics

Home » Autolus Therapeutics

IPO

Autolus Therapeutics

We are a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer

Symbol

AUTL

Price Range
$15.00 - $17.00

Final Shares
7,800,000

Anticipated Date
TBD

Underwriters
Goldman Sachs & Co. LLC, Jefferies, Wells Fargo Securities, William Blair

To view the prospectus for Autolus Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253